Перегляд по Автору "Amosova, K.M."

Зараз показуються 1-4 з 4

ACE (I/D) and eNOS (T894G) genes’ polymorphisms influence new cardiovascular (CV) events: pharmacogenomic update on therapy

Ursuliak, U.; Amosova, K.M.; Pishak, V.P.; Sydorchuk, L.P.; Volkov, R.A.; Sydorchuk, I.I.; Sydorchuk, R.I. (Journal of Hypertension, 2010)
Endothelial dysfunction and system inflammatory response markers in hypertensive patients with acute myocardial infarction depending on polymorphism of ACE (I/D) and eNOS (894G>T)

Sydorchuk, A.; Sydorchuk, R.; Sydorchuk, L.; Amosova, K.M.; Sydorchuk, I.; Ursuliak, U. (J. Hypertension, 2014)
Influence of pharmacogenetically determined treatment on parameters of peripheral hemodynamics in patients with arterial hypertension

Sydorchuk, L.P.; Amosova, K.M. (The New Armenian Medical Journal, 2011)

Aim: To evaluate daily blood pressure monitoring (DBPM) data changes in patients with essential arterial hypertension (EAH) under the influence of pharmacogenetically determined treatment depending on genes polymorphisms ...
Pharmacogenetically determined treatment' influence Left Ventricular Mass Index (LVMI) in relation to polymorphisms of ACE, AGTR1, eNOS, PPAR-G2, ADRB1 genes in essential hypertensive (EAH) patients

Sydorchuk, L.; Amosova, K.M.; Sydorchuk, R.; Ursuliak, U.; Sydorchuk, I. (Eur. Heart J., 2010)

Зараз показуються 1-4 з 4

Пошук